Estimating the Projected Impact of Weight Loss on Obesity Prevalence and Healthcare Costs in a UK Population

Author(s)

Grasic K1, Holloway S2, Capucci S3
1Lane Clark & Peacock LLP, London, UK, 2Lane Clark & Peacock LLP, Winchester, HAM, UK, 3Novo Nordisk A/S, Søborg, Denmark

OBJECTIVES: People living with obesity typically incur higher healthcare costs than those with healthy weight, and these costs increase with obesity severity. We estimated the impact of weight loss in a UK population on the prevalence of obesity classes and associated healthcare costs.

METHODS: The analysis considered adults aged 20–<70 years, defined according to body mass index (BMI) as having obesity class I, II or III (30–<35 kg/m2, 35–<40 kg/m2 or ≥40 kg/m2, respectively). The estimated prevalence of each obesity class in the UK in 2033 was derived from the 2022 World Obesity Atlas, combined with 2021 Health Survey for England obesity estimates and 2019 data from the Discover electronic health record data set, which covers 2.8 million people living in North West London. The effects of 10% weight loss on the number of people in each obesity class and associated healthcare costs were estimated using the BMI distribution and costs observed in the 2019 Discover data, and scaled to the UK population.

RESULTS: Weight loss of 10% was estimated to result in a 47% reduction in the number of people with obesity in 2033, equating to 8.1 million fewer people in the UK <70 years old living with obesity (4.8, 2.0 and 1.3 million in obesity classes I, II and III, respectively). The estimated mean per-person annual cost reduction was £350 for moving from obesity class III to II, £207 for moving from obesity class II to I and £171 for moving from obesity class I to overweight. This would result in an estimated £2.5 billion annual cost saving, mostly contributed by people moving from obesity class I to overweight.

CONCLUSIONS: Our estimates of the obesity prevalence and cost reductions that could be achieved via weight loss highlight the potential impact of targeted weight management support.

Conference/Value in Health Info

2023-11, ISPOR Europe 2023, Copenhagen, Denmark

Value in Health, Volume 26, Issue 11, S2 (December 2023)

Code

EPH7

Disease

Diabetes/Endocrine/Metabolic Disorders (including obesity), No Additional Disease & Conditions/Specialized Treatment Areas

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×